| Groups |
No. |
Percentage of CD4+ CD25+ FOXP3+ |
P value |
TH 17% |
P value |
| Mean ± SD |
Mean ± SD |
| Control |
50 |
1.72 ± 1.27 |
|
0.61 ± 0.25 |
|
| Group (I) |
14 |
1.80 ± 0.83 |
>0.05 |
1.09 ±0.74 |
>0.05 |
| Group (II) |
48 |
1.49 ± 1.00 |
>0.05 |
1.19 ± 0.34 |
<0.001* |
| Group (III) |
38 |
1.01 ± 0.87 |
<0.001* |
1.62 ± 0.73 |
<0.001* |
*p value = 8.6 × 10-4<0.001 Highly Significant.
Th17% p values were 0.07NS for group I; 9 × 10-4 HS for group II and 7.1 × 10-4 HS for group III
p values of each group are in comparison to control group. |
|
